Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

Watertown, USA
480 Arsenal St
Building One
Watertown, MA, 02472
USA

People

Founder
CEO of Selecta RUS
Founder, Board of Directors and Vice Chairman on the Board
Founder
President and CEO
Vice President Finance
Board of Director
Board of Directors
Show All People

Funding

TOTAL $108M
FUNDING TOTAL $108M
Series B, 2/2009
Polaris Partners
Flagship Ventures
NanoDimension
Timothy A. Springer
$15.1M
Series C, 4/2010
OrbiMed Advisors
Polaris Partners
Flagship Ventures
NanoDimension
Leukon Investments
$15M
Grant, 8/2010
National Institute on Drug Abuse (NIDA)
$3M
Venture Round, 10/2011
$47.3M
Series D, 2/2012
RUSNANO
$22M
Partial Close, 4/2014
$5.29M

Tags

Selecta Biosciences

Selecta Biosciences is a biopharmaceutical company developing the first generation of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Our proprietary product platform technology combines recent advances in immunobiology with cutting-edge nanotechnology to develop targeted immunomodulatory nanoparticles.

Recent Milestones

Videos

Screenshots

Sources

  1. Selecta Biosciences, Inc. Closes $15.1M Series B Financing (selectabio.com) [edit]
  2. SELECTA CLOSES $15 MILLION SERIES C FINANCING (freshnews.com) [edit]
  3. Selecta Biosciences Receives $3M Grant (finsmes.com) [edit]
  4. Russian fund leads $94.5M investment in two Langer biotechs (fiercebiotech.com) [edit]
  5. Selecta Biosciences, Inc.: Series D $22M (onbiovc.com) [edit]
  6. SEC (sec.gov) [edit]
Edit This Page
Last Edited 4/10/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy